Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Economic Evaluation of Anticyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis.

An J, Bider-Canfield Z, Kang J, Alemao E, Connolly SE, Lin AT, Cheetham TC.

J Manag Care Spec Pharm. 2019 Apr;25(4):469-477. doi: 10.18553/jmcp.2019.25.4.469.

2.

Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry.

Harrold LR, Litman HJ, Connolly SE, Alemao E, Kelly S, Rebello S, Hua W, Kremer JM.

Rheumatol Ther. 2019 Jun;6(2):217-230. doi: 10.1007/s40744-019-0149-3. Epub 2019 Mar 13.

3.

Assessing the Effect of Packing the Sulcus on Image Quality in Equine Digital Radiography.

Rowan C, Puggioni A, Hoey SE, O'Leary JM, Kearney C, Connolly SE, Skelly C.

Vet Rec. 2019 Feb 16;184(7):221. doi: 10.1136/vr.104737. Epub 2019 Feb 2.

PMID:
30711918
4.

Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry.

Alemao E, Litman HJ, Connolly SE, Kelly S, Hua W, Rosenblatt L, Rebello S, Kremer JM, Harrold LR.

J Rheumatol. 2018 Oct;45(10):1353-1360. doi: 10.3899/jrheum.171050. Epub 2018 Jul 1.

5.

Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study.

Jansen DTSL, Emery P, Smolen JS, Westhovens R, Le Bars M, Connolly SE, Ye J, Toes REM, Huizinga TWJ.

RMD Open. 2018 Mar 30;4(1):e000564. doi: 10.1136/rmdopen-2017-000564. eCollection 2018.

6.

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.

Bandyopadhyay S, Connolly SE, Jabado O, Ye J, Kelly S, Maldonado MA, Westhovens R, Nash P, Merrill JT, Townsend RM.

Lupus Sci Med. 2017 Jul 28;4(1):e000206. doi: 10.1136/lupus-2017-000206. eCollection 2017.

7.

Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study.

Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM.

J Rheumatol. 2018 Jan;45(1):32-39. doi: 10.3899/jrheum.170007. Epub 2017 Nov 1.

8.

Use of Digital Pupillometry to Measure Sedative Response to Propofol.

Haddock JH, Mercante DE, Paccione R, Breaux JL, Jolley SE, Johnson JL, Connolly SE, deBoisblanc BP.

Ochsner J. 2017 Fall;17(3):250-253.

9.

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM.

Clin Rheumatol. 2017 Jun;36(6):1215-1220. doi: 10.1007/s10067-017-3588-7. Epub 2017 Mar 1.

10.

Reply.

Fleischmann R, Connolly SE, Maldonado MA, Schiff M.

Arthritis Rheumatol. 2017 Apr;69(4):867-868. doi: 10.1002/art.40021. Epub 2017 Feb 28. No abstract available.

11.

Percutaneous Image-Guided Cryoablation of Musculoskeletal Metastases: Pain Palliation and Local Tumor Control.

Wallace AN, McWilliams SR, Connolly SE, Symanski JS, Vaswani D, Tomasian A, Vyhmeister R, Lee AM, Madaelil TP, Hillen TJ, Jennings JW.

J Vasc Interv Radiol. 2016 Dec;27(12):1788-1796. doi: 10.1016/j.jvir.2016.07.026. Epub 2016 Oct 13.

PMID:
27745968
12.

Brief Report: Estimating Disease Activity Using Multi-Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab.

Fleischmann R, Connolly SE, Maldonado MA, Schiff M.

Arthritis Rheumatol. 2016 Sep;68(9):2083-9. doi: 10.1002/art.39714.

13.

Improving Endoscopic Adherence to Quality Metrics in Colonoscopy.

Lu JJ, Decker CH, Connolly SE.

Ochsner J. 2015 Winter;15(4):413-7.

14.

Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells.

Patakas A, Ji RR, Weir W, Connolly SE, Benson RA, Nadler SG, Brewer JM, McInnes IB, Garside P.

Arthritis Rheumatol. 2016 Mar;68(3):627-38. doi: 10.1002/art.39470.

15.

Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial.

Sokolove J, Schiff M, Fleischmann R, Weinblatt ME, Connolly SE, Johnsen A, Zhu J, Maldonado MA, Patel S, Robinson WH.

Ann Rheum Dis. 2016 Apr;75(4):709-14. doi: 10.1136/annrheumdis-2015-207942. Epub 2015 Sep 10.

16.

The Third Esophageal Sphincter: A Case of Dysphagia Lusoria.

Breaux J, Gupta N, Smith R, Connolly SE.

ACG Case Rep J. 2014 Oct 10;2(1):6-7. doi: 10.14309/crj.2014.64. eCollection 2014 Oct. No abstract available.

17.

Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues.

Kant CD, Akiyama Y, Tanaka K, Shea S, Yamada Y, Connolly SE, Marino J, Tocco G, Benichou G.

J Immunol. 2015 Feb 1;194(3):1364-71. doi: 10.4049/jimmunol.1401157. Epub 2014 Dec 22.

18.

Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.

Kant CD, Akiyama Y, Tanaka K, Shea S, Connolly SE, Germana S, Winn HJ, LeGuern C, Tocco G, Benichou G.

J Immunol. 2013 Aug 15;191(4):1948-56. doi: 10.4049/jimmunol.1202092. Epub 2013 Jul 5.

19.

Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients.

Helbok R, Kurtz P, Schmidt MJ, Stuart MR, Fernandez L, Connolly SE, Lee K, Schmutzhard E, Mayer SA, Claassen J, Badjatia N.

Crit Care. 2012 Nov 27;16(6):R226. doi: 10.1186/cc11880.

20.

Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome.

Helbok R, Kurtz P, Vibbert M, Schmidt MJ, Fernandez L, Lantigua H, Ostapkovich ND, Connolly SE, Lee K, Claassen J, Mayer SA, Badjatia N.

J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):266-70. doi: 10.1136/jnnp-2012-302804. Epub 2012 Sep 25.

21.

Current status of chromoendoscopy and narrow band imaging in colonoscopy.

Nass JP, Connolly SE.

Clin Colon Rectal Surg. 2010 Feb;23(1):21-30. doi: 10.1055/s-0030-1247853.

22.

Evaluation of medical student experience using medical student created StudentPACS flash based PACS simulator tutorials for learning radiological topics.

Soman S, Amorosa JK, Mueller L, Hu J, Zou L, Masand A, Cheng C, Virk J, Rama H, Tseng I, Patel K, Connolly SE.

Acad Radiol. 2010 Jun;17(6):799-807. doi: 10.1016/j.acra.2010.01.016. Epub 2010 Mar 20.

PMID:
20303802
23.

The versatile roles of antibodies in Borrelia infections.

Connolly SE, Benach JL.

Nat Rev Microbiol. 2005 May;3(5):411-20. Review.

PMID:
15864264
24.

Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia.

Connolly SE, Thanassi DG, Benach JL.

J Immunol. 2004 Jan 15;172(2):1191-7.

25.
26.

Salvage of vision after hypotension-induced ischemic optic neuropathy.

Connolly SE, Gordon KB, Horton JC.

Am J Ophthalmol. 1994 Feb 15;117(2):235-42.

PMID:
8116753
27.

Labeled Schwann cell transplants versus sural nerve grafts in nerve repair.

Kim DH, Connolly SE, Kline DG, Voorhies RM, Smith A, Powell M, Yoes T, Daniloff JK.

J Neurosurg. 1994 Feb;80(2):254-60.

PMID:
8283264
28.

Comparison of macropore, semipermeable, and nonpermeable collagen conduits in nerve repair.

Kim DH, Connolly SE, Zhao S, Beuerman RW, Voorhies RM, Kline DG.

J Reconstr Microsurg. 1993 Nov;9(6):415-20.

PMID:
8283421
29.
30.

Electrophysiological studies of various graft lengths and lesion lengths in repair of nerve gaps in primates.

Kim DH, Connolly SE, Gillespie JT, Voorhies RM, Kline DG.

J Neurosurg. 1991 Sep;75(3):440-6.

PMID:
1869946
31.

Initial evaluation of variable graft lengths and lesion lengths in the repair of nerve gaps.

Kim DH, Connolly SE, Voorhies RM, Beuerman RW, Kline DG.

J Reconstr Microsurg. 1990 Oct;6(4):311-6.

PMID:
2269951
32.

A prototype retractor system designed to minimize ischemic brain retractor injury: initial observations.

Waring AJ, Housworth CM, Voorhies RM, Douglas JR, Walker CF, Connolly SE.

Surg Neurol. 1990 Sep;34(3):139-43.

PMID:
2385819
33.

Characterization of vascular development in the mouse retina.

Connolly SE, Hores TA, Smith LE, D'Amore PA.

Microvasc Res. 1988 Nov;36(3):275-90.

PMID:
2466191

Supplemental Content

Loading ...
Support Center